Literature DB >> 24419515

Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome.

K Patel1, M Nusrat2, N Shah3, Q Bashir3, S Parmar3, J Shah4, S Thomas4, D Weber4, R Z Orlowski4, R Champlin3, M H Qazilbash3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24419515      PMCID： PMC4157181          DOI： 10.1038/bmt.2013.209

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  POEMS syndrome with severe neurological damage clinically recovered with lenalidomide.

Authors:  José F Tomás; Pilar Giraldo; Ramón Lecumberri; Sara Nistal
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

2.  Successful bortezomib-based treatment in POEMS syndrome.

Authors:  Xiaowen Tang; Xiaolan Shi; Aining Sun; Huiying Qiu; Bin Gu; Huifen Zhou; Shengli Xue; Yuejun Liu; Changgeng Ruan; Depei Wu
Journal:  Eur J Haematol       Date:  2009-08-06       Impact factor: 2.997

3.  International uniform response criteria for multiple myeloma.

Authors:  B G M Durie; J-L Harousseau; J S Miguel; J Bladé; B Barlogie; K Anderson; M Gertz; M Dimopoulos; J Westin; P Sonneveld; H Ludwig; G Gahrton; M Beksac; J Crowley; A Belch; M Boccadaro; M Cavo; I Turesson; D Joshua; D Vesole; R Kyle; R Alexanian; G Tricot; M Attal; G Merlini; R Powles; P Richardson; K Shimizu; P Tosi; G Morgan; S V Rajkumar
Journal:  Leukemia       Date:  2006-07-20       Impact factor: 11.528

4.  Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation.

Authors:  W J Hogan; M Q Lacy; G A Wiseman; R D Fealey; A Dispenzieri; M A Gertz
Journal:  Bone Marrow Transplant       Date:  2001-08       Impact factor: 5.483

Review 5.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

Review 6.  Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

Authors:  Satoshi Kuwabara; Angela Dispenzieri; Kimiyoshi Arimura; Sonoko Misawa; Chiaki Nakaseko
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

7.  Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome.

Authors:  Jian Li; Wei Zhang; Li Jiao; Ming-Hui Duan; Hong-Zhi Guan; Wei-Guo Zhu; Zhuang Tian; Dao-Bin Zhou
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

8.  Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature.

Authors:  Angela Dispenzieri; Alvaro Moreno-Aspitia; Guillermo A Suarez; Martha Q Lacy; Gerardo Colon-Otero; Ayalew Tefferi; Mark R Litzow; Vivek Roy; William J Hogan; Robert A Kyle; Morie A Gertz
Journal:  Blood       Date:  2004-07-27       Impact factor: 22.113

9.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature.

Authors:  P A Bardwick; N J Zvaifler; G N Gill; D Newman; G D Greenway; D L Resnick
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

Review 10.  New advances in the diagnosis and treatment of POEMS syndrome.

Authors:  Jian Li; Dao-bin Zhou
Journal:  Br J Haematol       Date:  2013-02-08       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.